Share of cumulative clinical trial starts worldwide 2000-2018, by cancer indication
This statistic depicts the percentage of cumulative clinical trials started globally between 2000 and 2018, by cancer type. During these years, lung cancer-related clinical trials made up 3.1 percent of all clinical trials, followed closely by breast cancer with three percent of clinical trials started.